RecallRadar

FDA Device recall Z-0372-2023

NextAR Shoulder Surgical Technique, Shoulder NextAR RSA Platform, CT based computer-assisted surgical navigation platform used to perform a…

On 2022-12-14 the FDA classified a Class II recall of NextAR Shoulder Surgical Technique, Shoulder NextAR RSA Platform, CT based computer-assisted surgical navigation platform used to perform a… by Medacta Usa, citing A warning has been added to the Surgical Technique for NextAR Shoulder, advising verification of suitable patient conditions prior to placement of the NextAR Shoulder Target Holde….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-0372-2023
ClassificationClass II
Statusterminated
Initiated2022-10-27
Published2022-12-14
Last updated2026-09-13 11:56 UTC
CompanyMedacta Usa
DistributionAL, AR, CO, FL, IL, NH, SC

Product

NextAR Shoulder Surgical Technique, Shoulder NextAR RSA Platform, CT based computer-assisted surgical navigation platform used to perform a reverse shoulder arthroplasty on the glenoid

Reason

A warning has been added to the Surgical Technique for NextAR Shoulder, advising verification of suitable patient conditions prior to placement of the NextAR Shoulder Target Holder: WARNING Target fixation requires adequate coracoid bone stability. Osteoporosis, weakness of the coracoid process, or other deficiencies, could lead to adverse events including bone fracture. Verify that the coracoid bone and relevant patient conditions are suitable before proceeding.

Identifiers

code_infoDocument Reference Code 99.81NEXTAR.12US (for US market only), Revision Numbers: Rev.02 and previous

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:56 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0372-2023%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.